Aarti Drugs Limited — Call Transcript 2020

Oct 23, 2020

==> picture [477 x 82] intentionally omitted <==

Ref: ADL/SE/2020-21 October 23, 2020

To, Listing/ Compliance Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001

To, Listing/ Compliance Department National Stock Exchange of India Limited, “Exchange Plaza”, Bandra - Kurla Complex, Bandra (E), Mumbai – 400051

BSE CODE – 524348

NSE SYMBOL: AARTIDRUGS

Dear Sir/Madam,

Ref : Regulation 30(6) of SEBI (LODR) Regulations, 2015 Sub: Intimation of Conference Call

This is to inform you that Quarterly Conference Call for the Investors and Analysts has been scheduled on Monday, October 26, 2020 at 3:00 PM IST to discuss the Company’s Q2 FY21 Results. Please find attached herewith invitation for the same.

Kindly take the same on record.

Thanking you,

Yours faithfully,

FOR AARTI DRUGS LIMITED

==> picture [88 x 35] intentionally omitted <==

RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527

==> picture [468 x 32] intentionally omitted <==

Centrum Broking Limited Cordially invites you to a

Conference Call

with Management of

Aarti Drugs Ltd.

Agenda: Discussion on Q2FY21 results & future outlook

		Company Management
		Mr. Harshit Savla		Jt. Managing Director
		Mr. Harit Shah		Wholetime Director
		Mr. Adhish Patil		CFO
		Express Login		Diamond Pass Registration
		Conference Dial-In Numbers
		Primary Number:		+91 22 6280 1210 / +91 22 7115 8111
		Secondary Number:		+91 70456 71221
				USA : 1 866 746 2133
				UK : 0 808 101 1573
		International Toll Free Numbers:
				Singapore : 800 101 2045
				Hong Kong : 800 964 448
		Date:		Monday, 26 October 2020
		Time:		3.00 PM IST
		RSVP:
		Ms. Cyndrella Carvalho
		Centrum Broking Limited
		Land line: +91 22 4215 9643
		Mob: +91 9823 615656
		E-mail: cyndrella.carvalho@centrum.co.in